News Sentiment

ALOPM sentiment intelligence

Oncodesign Precision Medicine Société anonyme news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 4 relevant articles
Exchange PAR France
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.34 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Deals and strategy

62/100 classification confidence.

Company focus 4

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+2.4% over one week, +0.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Enterprise value to revenue forward of Oncodesign Precision Medicine S.A. – EURONEXT:ALOPM

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Deals and strategy 62/100 classification
One-week reaction 2.4% Price confirming higher
Trend fit Trend inactive 0.0% over four weeks
Fair value -64.4% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 4
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 4
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Business Wire 3
TradingView 1

Event Lens

What the news is about

Classified themes
Deals and strategy 2
Earnings 1
Market update 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-4 of 4